Zhijian Han

机构：Lanzhou University of Technology, Lanzhou University Second Hospital, Lanzhou University · ORCID：0000-0002-3045-0913

发表论文 7 篇 · 总被引 170 次 · h-index 5

代表论文

• TCR-T Immunotherapy: The Challenges and Solutions (2022 · Frontiers in Oncology · 被引 114)
• Targeted Dual‐Responsive Liposomes Co‐Deliver Jolkinolide B and Ce6 to Synergistically Enhance the Photodynamic/Immunotherapy Efficacy in Gastric Cancer through the PANoptosis Pathway (2025 · Advanced Science · 被引 19)
• Recent Advances in Augmenting the Therapeutic Efficacy of Peptide–Drug Conjugates (2025 · Journal of Medicinal Chemistry · 被引 18)
• Recent Advancesin Peptide Linkers of Antibody–DrugConjugates (2025 · Journal of Medicinal Chemistry · 被引 14)
• Evaluation of a Novel Gd-FAPI Dimer Molecular Probe Targeting Fibroblast Activation Protein for Imaging of Solid Tumors (2025 · Molecular Pharmaceutics · 被引 6)
• Research progress on the relationship among Wilms’ tumor-1 gene and its coding proteins and tumor (2019 · Zhonghua shiyan waike zazhi)